Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 1225 of 3546 entries
View as:

Retreatment of Patients With Non-Hodgkin's Lymphoma Who Have Previously Responded to Iodine-131 Anti B1 Antibody

Phase: N/A Priority: Normal
NCT ID: NCT00938041 Org: User:
Start: 04/30/98 End: 06/30/13 Due: 06/30/14

Drisapersen Duchenne Muscular Dystrophy (DMD) Treatment Protocol

Phase: N/A Priority: Normal
NCT ID: NCT01890798 Org: User:
Start: 01/31/14 End: 07/31/15 Due: 07/31/16

GW572016 In Patients With ErbB2 Over - Expressing Advanced Or Metastatic Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00320411 Org: User:
Start: 11/28/05 End: 04/01/09 Due: 04/01/10

A Study to Evaluate the Safety, Efficacy and Changes in Induced Sputum and Blood Biomarkers Following Daily Repeat Doses of Inhaled GSK2269557 in Chronic Obstructive Pulmonary Disease (COPD) Subjects With Acute Exacerbation

Phase: N/A Priority: Normal
NCT ID: NCT02522299 Org: User:
Start: 11/04/15 End: 06/22/18 Due: 06/22/19

Assess the Non-inferiority of GSK Biologicals' Mencevax™ ACWY (Manufactured by a New Process) vs Mencevax™ ACWY (the Already Existing Vaccine in the Market) When Given as a Single Dose to Subjects Aged 2-30 Yrs

Phase: N/A Priority: Normal
NCT ID: NCT00227422 Org: User:
Start: 06/30/05 End: 11/30/05 Due: 11/30/06

Estimation of the Burden of Rotavirus Gastroenteritis (RV GE) in Children Less Than 5 Years in Greece

Phase: N/A Priority: Normal
NCT ID: NCT00751686 Org: User:
Start: 07/31/08 End: 03/31/10 Due: 03/31/11

Topical GW842470X In Adults Patients With Moderate Atopic Dermatitis

Phase: N/A Priority: Normal
NCT ID: NCT00354510 Org: User:
Start: 03/31/06 End: - Due: -

Anemia Studies in Chronic Kidney Disease: Erythropoiesis Via a Novel Prolyl Hydroxylase Inhibitor Daprodustat-Dialysis (ASCEND-D)

Phase: N/A Priority: Normal
NCT ID: NCT02879305 Org: User:
Start: 09/28/16 End: 11/09/20 Due: 11/09/21

First Time in Human Study With GSK1325756

Phase: N/A Priority: Normal
NCT ID: NCT01209052 Org: User:
Start: 10/15/09 End: 03/02/10 Due: 03/02/11

Rollover Study Of Lapatinib In Cancer Patients

Phase: N/A Priority: Normal
NCT ID: NCT00169533 Org: User:
Start: 08/19/04 End: 05/05/09 Due: 05/05/10

Study to Determine the Utility of Novel Technologies and Biomarkers to Measure Human Response to Rosiglitazone Maleate

Phase: N/A Priority: Normal
NCT ID: NCT00551564 Org: User:
Start: 07/31/07 End: 09/08/08 Due: 09/08/09

Total Hip Replacement Study Of GSK576428 (Fondaparinux Sodium)

Phase: N/A Priority: Normal
NCT ID: NCT00320398 Org: User:
Start: 01/30/06 End: 07/18/06 Due: 07/18/07

GW823296 Repeat Dose Study In Healthy Male And Female Subjects

Phase: N/A Priority: Normal
NCT ID: NCT00675116 Org: User:
Start: 04/30/08 End: 07/31/08 Due: 07/31/09

A Study to Evaluate Conceptual Saturation of Evaluating Respiratory Symptoms (E-RS) in Subjects With Asthma

Phase: N/A Priority: Normal
NCT ID: NCT03344406 Org: User:
Start: 12/01/17 End: 09/10/18 Due: 09/10/19

An Evaluation Of Mepolizumab In Therapy Of Eosinophilic Oesophagitis In Adult Patients

Phase: N/A Priority: Normal
NCT ID: NCT00274703 Org: User:
Start: 12/31/05 End: 03/31/07 Due: 03/31/08

A Comparison of Patients on AVAMYS ® Versus NASONEX (A Trade Mark of Schering Corporation) and FLIXONASE ® on Key Health Outcome Measures

Phase: N/A Priority: Normal
NCT ID: NCT01199757 Org: User:
Start: 07/10/09 End: 08/01/09 Due: 08/01/10

Safety and Immunogenicity of GlaxoSmithKline (GSK) Biologicals' Meningococcal B Recombinant Vaccine When Administered Concomitantly With Routine Vaccines to Healthy Infants of 2 Months of Age and Older, in Taiwan.

Phase: N/A Priority: Normal
NCT ID: NCT02173704 Org: User:
Start: 09/11/14 End: 06/17/16 Due: 06/17/17

Evaluation of Pazopanib on Bleeding in Subjects With Hereditary Haemorrhagic Telangiectasia

Phase: N/A Priority: Normal
NCT ID: NCT02204371 Org: User:
Start: 02/25/15 End: 02/10/16 Due: 02/10/17

Post-marketing Study to Assess the Safety of CERVARIX When Used in the United States and in Canada

Phase: N/A Priority: Normal
NCT ID: NCT01290393 Org: User:
Start: 09/26/11 End: 12/20/12 Due: 12/20/13

Study on the Burden of Influenza-related Hospitalizations and Emergency Room (ER) Visits in Children in Spain

Phase: N/A Priority: Normal
NCT ID: NCT01592799 Org: User:
Start: 11/23/10 End: 05/23/11 Due: 05/23/12

A Phase 3a, Repeat Dose, Open-label, Long-term Safety Study of Mepolizumab in Asthmatic Subjects

Phase: N/A Priority: Normal
NCT ID: NCT02135692 Org: User:
Start: 05/29/14 End: 10/05/17 Due: 10/05/18

A Study to Assess the Bronchodilator Effect of a Single Dose of Fluticasone Furoate (FF)/ Vilanterol (VI) 100/25 Micrograms (mcg) Combination When Administered in Adult Patients With Asthma

Phase: N/A Priority: Normal
NCT ID: NCT01837316 Org: User:
Start: 10/21/13 End: 08/08/14 Due: 08/08/15

Bioequivalence Study of Cephalexin Tablets 1g

Phase: N/A Priority: Normal
NCT ID: NCT01767584 Org: User:
Start: 04/06/09 End: 04/14/09 Due: 04/14/10

Special Drug Use Investigation for PAXIL Tablet (20mg-Clinical Symptom Progression)

Phase: N/A Priority: Normal
NCT ID: NCT01371461 Org: User:
Start: 01/31/04 End: 10/31/04 Due: 10/31/05

Evaluation of Pneumococcal Vaccine Formulations in Young Adults

Phase: N/A Priority: Normal
NCT ID: NCT00707798 Org: User:
Start: 06/30/08 End: 01/15/09 Due: 01/15/10